Why broadly neutralising antibodies might be the next big thing in HIV

Why broadly neutralising antibodies might be the next big thing in HIV

We know antiretroviral therapy can prevent HIV infection, but can natural biological substances do the same? The results of a recent scientific trial have answered this question: Yes, using broadly neutralising antibodies. But what are broadly neutralising antibodies? How do they work? And when will the average person get access to them? Amy Green breaks down the science.

Read More

COVID-19: Local researchers welcome Sputnik V vaccine findings

COVID-19: Local researchers welcome Sputnik V vaccine findings

Local researchers have welcomed impressive phase III findings for the Russian-made Sputnik V vaccine published this week in the Lancet medical journal. It is the sixth COVID-19 vaccine found to be effective in preliminary data from a phase III randomised controlled trial and the fourth to have phase III findings published in a leading medical journal.

Read More

WORLD AIDS DAY: How stigma is impacting the 90-90-90 goals

WORLD AIDS DAY: How stigma is impacting the 90-90-90 goals

The HIV epidemic is far from over and we will not reach key UNAIDS targets and control HIV unless we end HIV-related stigma, argues Prof Linda-Gail Bekker.

Read More

The promise of HIV prevention injections and how they work

The promise of HIV prevention injections and how they work

Antiretroviral (ARV) injections that may protect women from becoming HIV-positive, if proved to be safe and effective, will be a major step forward in the fight against the HIV pandemic. Siyabonga Kamnqa reports.

Read More

What is the state of the global HIV and TB response in December 2017?

What is the state of the global HIV and TB response in December 2017?

For World AIDS Day 2017 we asked a number of experts about the state of the global HIV and TB response. Read answers from Glenda Gray, Peter Piot, Stephen Lewis, Gregg Gonsalves, Linda-Gail Bekker, Anele Yawa, Quarraisha Abdool Karim, Robin Gorna, Tim Tucker and Yogan Pillay.

Read More